FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 340:227-228 January 21, 1999 Number 3 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

For more than two decades, the intravenous administration of high doses of IgG pooled from the plasma of healthy donors (immune globulin therapy, also known as "IVIg") has benefited patients with a variety of autoimmune disorders. Although its mechanism of action is not known, immune globulin is accepted as an effective and convenient alternative to plasmapheresis for treating diseases that are thought to be mediated by pathogenic autoantibodies or immune complexes.¹ It is used increasingly to treat neurologic diseases such as inflammatory demyelinating neuropathies, multifocal motor neuropathy, inflammatory myopathies, myasthenia gravis, and the Lambert–Eaton syndrome. The efficacy of immune globulin . . . [Full Text of this Article]

References

Related Letters:

Mechanism of Intravenous Immune Globulin Therapy
Spellberg B., Yu Z., Lennon V. A.
Extract | Full Text  
N Engl J Med 1999; 341:57-58, Jul 1, 1999. Correspondence

This article has been cited by other articles:

• Czernik, A., Bystryn, J.-C. (2008). Improvement of Intravenous Immunoglobulin Therapy for Bullous Pemphigoid by Adding Immunosuppressive Agents: Marked Improvement in Depletion of Circulating Autoantibodies. Arch Dermatol 144: 658-661 [Abstract] [Full Text]  
• Mezo, A. R., McDonnell, K. A., Hehir, C. A. T., Low, S. C., Palombella, V. J., Stattel, J. M., Kamphaus, G. D., Fraley, C., Zhang, Y., Dumont, J. A., Bitonti, A. J. (2008). Reduction of IgG in nonhuman primates by a peptide antagonist of the neonatal Fc receptor FcRn. Proc. Natl. Acad. Sci. USA 105: 2337-2342 [Abstract] [Full Text]  
• Ponticelli, C. (2006). New Therapies for Lupus Nephritis. CJASN 1: 863-868 [Full Text]  
• Ni, H., Chen, P., Spring, C. M., Sayeh, E., Semple, J. W., Lazarus, A. H., Hynes, R. O., Freedman, J. (2006). A novel murine model of fetal and neonatal alloimmune thrombocytopenia: response to intravenous IgG therapy. Blood 107: 2976-2983 [Abstract] [Full Text]  
• Ballow, M. (2005). Clinical and investigational considerations for the use of IGIV therapy. Am J Health Syst Pharm 62: S12-S18 [Abstract] [Full Text]  
• Lapointe, B. M., Herx, L. M., Gill, V., Metz, L. M., Kubes, P. (2004). IVIg therapy in brain inflammation: etiology-dependent differential effects on leucocyte recruitment. Brain 127: 2649-2656 [Abstract] [Full Text]  
• Danieli, M G, Cappelli, M, Malcangi, G, Logullo, F, Salvi, A, Danieli, G (2004). Long term effectiveness of intravenous immunoglobulin in Churg-Strauss syndrome. Ann Rheum Dis 63: 1649-1654 [Abstract] [Full Text]  
• Nishimoto, Y., Koga, M., Kamijo, M., Hirata, K., Yuki, N. (2004). Immunoglobulin improves a model of acute motor axonal neuropathy by preventing axonal degeneration. Neurology 62: 1939-1944 [Abstract] [Full Text]  
• Jiang, L., Wang, J., Solorzano-Vargas, R. S., Tsai, H. V., Gutierrez, E. M, Ontiveros, L. O., Kiela, P. R., Wu, S. V., Martin, M. G. (2004). Characterization of the rat intestinal Fc receptor (FcRn) promoter: transcriptional regulation of FcRn gene by the Sp family of transcription factors. Am. J. Physiol. Gastrointest. Liver Physiol. 286: G922-G931 [Abstract] [Full Text]  
• Walk, D., Li, L. Y.J., Parry, G. J., Day, J. W. (2004). Rapid resolution of quadriplegic CIDP by combined plasmapheresis and IVIg. Neurology 62: 155-156 [Full Text]  
• Lewis, M, Gibson, T (2003). Systemic lupus erythematous with recurrent Guillain -Barre-like syndrome treated with intravenous immunoglobulins. Lupus 12: 857-859 [Abstract]  
• Jacobs, B. C., O'Hanlon, G. M., Bullens, R. W. M., Veitch, J., Plomp, J. J., Willison, H. J. (2003). Immunoglobulins inhibit pathophysiological effects of anti-GQ1b-positive sera at motor nerve terminals through inhibition of antibody binding. Brain 126: 2220-2234 [Abstract] [Full Text]  
• Katz, K. A., Hivnor, C. M., Geist, D. E., Shapiro, M., Ming, M. E., Werth, V. P. (2003). Stroke and Deep Venous Thrombosis Complicating Intravenous Immunoglobulin Infusions. Arch Dermatol 139: 991-993 [Full Text]  
• de Grandmont, M. J., Racine, C., Roy, A., Lemieux, R., Neron, S. (2003). Intravenous immunoglobulins induce the in vitro differentiation of human B lymphocytes and the secretion of IgG. Blood 101: 3065-3073 [Abstract] [Full Text]  
• Bernstein, W. B, Trotta, R. F, Rector, J. T, Tjaden, J. A, Barile, A. J (2003). Mechanisms for Linezolid-Induced Anemia and Thrombocytopenia. The Annals of Pharmacotherapy 37: 517-520 [Abstract] [Full Text]  
• Takahashi, Y., Takata, T., Hoshino, M., Sakurai, M., Kanazawa, I. (2003). Benefit of IVIG for long-standing ataxic sensory neuronopathy with Sjogren's syndrome. Neurology 60: 503-505 [Abstract] [Full Text]  
• Bayry, J., Lacroix-Desmazes, S., Carbonneil, C., Misra, N., Donkova, V., Pashov, A., Chevailler, A., Mouthon, L., Weill, B., Bruneval, P., Kazatchkine, M. D., Kaveri, S. V. (2003). Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin. Blood 101: 758-765 [Abstract] [Full Text]  
• Dalakas, M. C. (2002). Mechanisms of action of IVIg and therapeutic considerations in the treatment of acute and chronic demyelinating neuropathies. Neurology 59: S13-21 [Abstract] [Full Text]  
• Hansen, R. J., Balthasar, J. P. (2002). Effects of intravenous immunoglobulin on platelet count and antiplatelet antibody disposition in a rat model of immune thrombocytopenia. Blood 100: 2087-2093 [Abstract] [Full Text]  
• Dalakas, M. C., Fujii, M., Li, M., Lutfi, B., Kyhos, J., McElroy, B. (2001). High-Dose Intravenous Immune Globulin for Stiff-Person Syndrome. NEJM 345: 1870-1876 [Abstract] [Full Text]  
• Bleeker, W. K., Teeling, J. L., Hack, C. E. (2001). Accelerated autoantibody clearance by intravenous immunoglobulin therapy: studies in experimental models to determine the magnitude and time course of the effect. Blood 98: 3136-3142 [Abstract] [Full Text]  
• Kishimoto, C., Takada, H., Kawamata, H., Umatake, M., Ochiai, H. (2001). Immunoglobulin Treatment Prevents Congestive Heart Failure in Murine Encephalomyocarditis Viral Myocarditis Associated with Reduction of Inflammatory Cytokines. J. Pharmacol. Exp. Ther. 299: 645-651 [Abstract] [Full Text]  
• Boon, L., Brok, H. P. M., Bauer, J., Ortiz-Buijsse, A., Schellekens, M. M., Ramdien-Murli, S., Blezer, E., van Meurs, M., Ceuppens, J., de Boer, M., 't Hart, B. A., Laman, J. D. (2001). Prevention of Experimental Autoimmune Encephalomyelitis in the Common Marmoset (Callithrix jacchus) Using a Chimeric Antagonist Monoclonal Antibody Against Human CD40 Is Associated with Altered B Cell Responses. J. Immunol. 167: 2942-2949 [Abstract] [Full Text]  
• Genevay, S, Saudan-Kister, A, Guerne, P-A (2001). Intravenous gammaglobulins in refractory polymyositis: lower dose for maintenance treatment is effective. Ann Rheum Dis 60: 635-636 [Abstract] [Full Text]  
• Schmaldienst, S., Mullner, M., Goldammer, A., Spitzauer, S., Banyai, S., Horl, W. H., Derfler, K. (2001). Intravenous immunoglobulin application following immunoadsorption: benefit or risk in patients with autoimmune diseases?. Rheumatology (Oxford) 40: 513-521 [Abstract] [Full Text]  
• Hundt, M., Manger, K., Dorner, T., Grimbacher, B., Kalden, P., Rascu, A., Weber, D., Burmester, G. R., Peter, H. H., Kalden, J. R., Schmidt, R. E. (2000). Treatment of acute exacerbation of systemic lupus erythematosus with high-dose intravenous immunoglobulin. Rheumatology (Oxford) 39: 1301-1302 [Full Text]  
• Vernino, S., Low, P. A., Fealey, R. D., Stewart, J. D., Farrugia, G., Lennon, V. A. (2000). Autoantibodies to Ganglionic Acetylcholine Receptors in Autoimmune Autonomic Neuropathies. NEJM 343: 847-855 [Abstract] [Full Text]  
• Revel-Vilk, S., Hurvitz, H., Klar, A., Virozov, Y., Kom-Lubetzki, I. (2000). Recurrent Acute Disseminated Encephalomyelitis Associated With Acute Cytomegalovirus and Epstein-Barr Virus Infection. J Child Neurol 15: 421-424 [Abstract]  
• Shinkai, K., Locksley, R. M. (2000). CD1, Tuberculosis, and the Evolution of Major Histocompatibility Complex Molecules. JEM 191: 907-914 [Full Text]  
• Hammerman, C., Kaplan, M. (2000). Recent Developments in the Management of Neonatal Hyperbilirubinemia. NeoReviews 1: e19-24 [Full Text]  
• Muller, J., Wallukat, G., Dandel, M., Bieda, H., Brandes, K., Spiegelsberger, S., Nissen, E., Kunze, R., Hetzer, R. (2000). Immunoglobulin Adsorption in Patients With Idiopathic Dilated Cardiomyopathy. Circulation 101: 385-391 [Abstract] [Full Text]  
• Spellberg, B., Yu, Z., Lennon, V. A. (1999). Mechanism of Intravenous Immune Globulin Therapy. NEJM 341: 57-58 [Full Text]  
• Stangel, M., Toyka, K. V., Gold, R. (1999). Mechanisms of High-Dose Intravenous Immunoglobulins in Demyelinating Diseases. Arch Neurol 56: 661-663 [Abstract] [Full Text]